Monday, 14. September 2026دربارهٔ ماتماس
Tribune Farsiصدای مستقلِ تحلیل
One in Six Women May Develop This Liver Disease
Health

One in Six Women May Develop This Liver Disease

منبع تصویر: theconversation.com

By 2 min Read time 48,327

According to new research, one in six women may be affected by non-alcoholic fatty liver disease (NAFLD). This condition, commonly referred to as a silent disease, can pose serious complications for pregnant women. In this analysis, we will explore various aspects of this disease and its implications during pregnancy.

Background of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease is one of the most common liver diseases, characterized by the accumulation of fat in the liver without alcohol consumption being recognized as the primary cause. This disease can gradually lead to inflammation, fibrosis, and ultimately liver cirrhosis. Since this disease is usually asymptomatic, it is often diagnosed at more advanced stages.

Research indicates that various factors such as obesity, type 2 diabetes, and metabolic disorders can increase the risk of developing NAFLD. Given the rising prevalence of this disease in society, especially among women, paying attention to its consequences during pregnancy is of particular importance.

Complications of the Disease During Pregnancy

Pregnant women with NAFLD may face complications that can threaten the health of both the mother and the fetus. One such complication is the risk of preeclampsia, which can lead to high blood pressure and serious problems for both mother and fetus. Additionally, pregnant women may be at risk of premature birth and low birth weight infants.

Research has shown that NAFLD can also increase the risk of gestational diabetes. This issue not only affects the mother's health but can also have serious consequences for the newborn. Therefore, identifying and managing this disease during pregnancy is of high importance.

Preventive and Therapeutic Measures

Given the risks associated with this disease, preventive and therapeutic measures for pregnant women with NAFLD are essential. Lifestyle changes such as dietary modifications, regular exercise, and weight management can help reduce the risks associated with this disease. Furthermore, regular monitoring of liver health and necessary testing is also recommended.

Ultimately, it seems that attention to non-alcoholic fatty liver disease and its consequences during pregnancy requires greater awareness from both physicians and women. With increased awareness and early diagnosis, it is possible to improve the health of mothers and newborns and reduce the serious complications of this disease.

Source: theconversation.com